| Identifier |
20180306_nanos_posters_170 |
| Title |
Baseline OCT Findings in Phase 3 RESCUE and REVERSE Trials |
| Creator |
Robert Sergott; Barrett Katz |
| Affiliation |
(RS) Wills Eye and Thomas Jefferson University, Philadelphia, PA; (BK) Montefiore Medical Center, New York, NY |
| Subject |
Genetic Disease, Optic Neuropathy; Diagnostic Tests (ERG, VER, OCT, HRT, mfERG, etc); Eyelid & Adnexal Disease |
| Description |
rAAV2/2-ND4 is an investigational gene therapy facilitating allotopic transgene expression. We report baseline spectral domain OCT of the RNFL and GCL in two Phase 3 trials. |
| Date |
2018-03 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2018 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2018: Poster Presentations |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s61013gq |
| Setname |
ehsl_novel_nam |
| ID |
1309590 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s61013gq |
